Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pacritinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    2022 drug approvals: Biopharma delivered 37 new drugs
    2022 drug approvals: Biopharma delivered 37 new drugs

    03 Jan 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/special-reports/2022-drug-approvals-after-aduhelm-fiasco-fda-endorsements-were-harder-come

    Kevin Dunleavy FIERCE PHARMA
    03 Jan 2023
    Share Share
    CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at ASH
    CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at ASH

    11 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cti-biopharma-presents-new-anemia-benefit-data-from-pacritinib-program-at-the-2022-american-society-of-hematology-ash-annual-meeting-and-exposition-301698750.html

    PRNEWSWIRE
    11 Dec 2022
    Share Share
    CTI Announces Presentation of Anemia Benefit Data from Pacritinib Program
    CTI Announces Presentation of Anemia Benefit Data from Pacritinib Program

    21 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cti-biopharma-announces-presentation-of-new-anemia-benefit-data-from-pacritinib-program-at-the-society-of-hematologic-oncology-soho-tenth-annual-meeting-301630200.html

    PRNEWSWIRE
    21 Sep 2022
    Share Share
    CTI BioPharma Presents Pivotal Data from Pacritinib Program at EHA
    CTI BioPharma Presents Pivotal Data from Pacritinib Program at EHA

    10 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cti-biopharma-presents-pivotal-data-from-pacritinib-program-at-the-european-hematology-association-eha-2022-congress-301565554.html

    PRNEWSWIRE
    10 Jun 2022
    Share Share
    NCCN Guidelines Recommend VONJO for Myeloproliferative Neoplasms
    NCCN Guidelines Recommend VONJO for Myeloproliferative Neoplasms

    14 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nccn-guidelines-recommend-vonjo-pacritinib-for-the-treatment-of-myeloproliferative-neoplasms-301525508.html

    PRNEWSWIRE
    14 Apr 2022
    Share Share
    VONJO Approved for Myelofibrosis with Platelet Count Below 50 x 109/L
    VONJO Approved for Myelofibrosis with Platelet Count Below 50 x 109/L

    04 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220304005492/en

    BUSINESSWIRE
    04 Mar 2022
    Share Share